Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)- a Cluster Randomized Controlled Study

NCT05444348 is registered in ClinicalTrials.gov with Christoffer Johansen as lead sponsor.

NCT NCT05444348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)- a Cluster Randomized Controlled Study
Lead sponsor
Christoffer Johansen
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2022
Completion date
July 1, 2028
Enrollment
920 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes